Peking University First Hospital
Clinical trials sponsored by Peking University First Hospital, explained in plain language.
-
Promising drug for painful hand and foot pustules fails to recruit enough patients
Disease control TerminatedThis study aimed to see if deucravacitinib, a pill taken daily, could reduce pustules and improve quality of life in people with moderate-to-severe palmoplantar pustulosis (PPP). Only 3 people enrolled before the trial was stopped early. The drug works by calming the immune syste…
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 26, 2026 03:21 UTC
-
New pain drug shows promise for Post-Surgery relief, but study cut short
Symptom relief TerminatedThis study tested a drug called anrikefon for treating deep internal pain after laparoscopic surgery. The drug was given through a pump that patients could control. The trial was stopped early and only included 13 adults having stomach surgery. The goal was to see if anrikefon co…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated May 26, 2026 03:10 UTC
-
50,000-Patient study probes Anesthesia's link to Post-Surgery heart attacks and strokes
Knowledge-focused TerminatedThis study looked at 50,000 adults who had non-cardiac surgery under general anesthesia to see if the type of anesthesia drugs used affected their risk of serious heart or brain problems afterward. The goal was to find out if certain anesthesia methods are safer. The study was st…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:11 UTC